Cargando…
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays
BACKGROUND: Imatinib mesylate has been a breakthrough treatment for chronic myeloid leukemia. It has become the ideal tyrosine kinase inhibitor and the standard treatment for chronic-phase leukemia. Striking results have recently been reported, but intolerance to imatinib and noncompliance with trea...
Autores principales: | Rezende, Vinicius Marcondes, Rivellis, Ariane, Novaes, Mafalda Megumi Yoshinaga, de Alencar Fisher Chamone, Dalton, Bendit, Israel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739544/ https://www.ncbi.nlm.nih.gov/pubmed/23946646 http://dx.doi.org/10.2147/DDDT.S42902 |
Ejemplares similares
-
Determination of serum levels of imatinib mesylate in patients with
chronic myeloid leukemia: validation and application of a new analytical method to
monitor treatment compliance
por: Rezende, Vinícius Marcondes, et al.
Publicado: (2013) -
The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
por: Conchon, Monika, et al.
Publicado: (2009) -
Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019) -
Quantification of Colistin in Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study
por: Matar, Kamal M., et al.
Publicado: (2020) -
Quantification of Protein Phosphorylation by Liquid Chromatography−Mass Spectrometry
por: Previs, Michael J., et al.
Publicado: (2008)